CM
XERS icon

Caption Management’s Xeris Biopharma Holdings XERS Stock Holding History

Caption Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.34M Buy
403,400
+280,000
+227% +$1.86M 0.01% 780
2025
Q4 		$969K Buy
+123,400
New +$971K 0.01% 1065
2024
Q1 		– Sell
-44,400
Closed -$104K – 1718
2023
Q4 		$104K Hold
44,400
– – ﹤0.01% 1175
2023
Q3 		$82.6K Hold
44,400
– – ﹤0.01% 1165
2023
Q2 		$116K Buy
+44,400
New +$113K ﹤0.01% 973

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caption Management's XERS Position: Q1 2026 in Review

Caption Management opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 205,000 shares worth $1.19M. The stake represents 0.01% of the portfolio and ranks #965 among its holdings. This is a return to the name: Caption Management previously reported a position in XERS as recently as Q4 2021.

Caption Management first reported a position in XERS in Q4 2021 and has held it in 2 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Caption Management held 205,000 shares of Xeris Biopharma Holdings worth $1.19M as of Q1 2026.
  • Xeris Biopharma Holdings was a new Caption Management position in Q1 2026.
  • Xeris Biopharma Holdings made up 0.01% of Caption Management's portfolio in Q1 2026, its #965 holding.
  • Caption Management first reported a position in Xeris Biopharma Holdings in Q4 2021 and has held it in 2 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.